Eric G. Butchart

Management and outcomes in patients with moderate or severe functional mitral regurgitation and severe left ventricular dysfunction

2017 AHA/ACC Focused Update of the 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines

2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM Guidelines for the Diagnosis and Management of Patients With Thoracic Aortic Disease

Long-Term Safety and Effectiveness of Mechanical Versus Biologic Aortic Valve Prostheses in Older Patients

Long-Term Outcomes of Mechanical Valve Replacement in Patients With Atrial Fibrillation

Transcatheter Valve-in-Valve Implantation for Failed Bioprosthetic Heart Valves

2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease

2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: Executive Summary

Rheumatic mitral valve repair: 22-year clinical results.

Recommendations for Cardiac Chamber Quantification by Echocardiography in Adults: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging

2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary

Late Outcomes for Aortic Valve Replacement With the Carpentier-Edwards Pericardial Bioprosthesis: Up to 17-Year Follow-Up in 1,000 Patients

EAE/ASE Recommendations for the Use of Echocardiography in New Transcatheter Interventions for Valvular Heart Disease

Antithrombotic management of patients with prosthetic heart valves: current evidence and future trends

Pharmacology and Management of the Vitamin K Antagonists

Extrapleural Pneumonectomy in the Multimodality Therapy of Malignant Pleural Mesothelioma

Autograft and pulmonary allograft performance in the second post-operative decade after the Ross procedure: insights from the Rotterdam Prospective Cohort Study

Drug Insight: an overview of current anticoagulation therapy after heart valve replacement

Acute and 12-Month Results With Catheter-Based Mitral Valve Leaflet Repair

Resection margins, extrapleural nodal status, and cell type determine postoperative long-term survival in trimodality therapy of malignant pleural mesothelioma: Results in 183 patients

Doppler echocardiographic evaluation of prosthetic valve function

Noninferiority of Closely Monitored Mechanical Valves to Bioprostheses Overshadowed by Early Mortality Benefit in Younger Patients

A comparison of dabigatran etexilate with warfarin in patients with mechanical heart valves: The Randomized, phase II study to Evaluate the sAfety and pharmacokinetics of oraL dabIGatran etexilate in patients after heart valve replacemeNt (RE-ALIGN)

A propensity score-adjusted retrospective comparison of early and mid-term results of mitral valve repair versus replacement in octogenarians

Photodynamic Therapy

Thromboembolic and Bleeding Complications Following St. Jude Medical Valve Replacement

Surgical treatment of multivalvular endocarditis: Twenty-one–year single center experience

One-year outcomes and predictors of mortality after MitraClip therapy in contemporary clinical practice: results from the German transcatheter mitral valve interventions registry

Mitral valve disease—current management and future challenges

Choice of Prosthetic Heart Valve in Adults

Malignant mesothelioma—British surgical strategies

Impact of Severe Mitral Regurgitation on Postoperative Outcomes After Noncardiac Surgery

Maternal and fetal sequelae of anticoagulation during pregnancy in patients with mechanical heart valve prostheses

2008 Focused Update Incorporated Into the ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease

Promising Early Local Control of Malignant Pleural Mesothelioma Following Postoperative Intensity Modulated Radiotherapy (IMRT) to the Chest

Association Between CYP2C9 Genetic Variants and Anticoagulation-Related Outcomes During Warfarin Therapy

Diagnostic evaluation of left-sided prosthetic heart valve dysfunction

Percutaneous Repair or Surgery for Mitral Regurgitation

Prediction of valve prosthesis–patient mismatch prior to aortic valve replacement: which is the best method?

Valve-Sparing Root Replacement Compared With Composite Valve Graft Procedures in Patients With Aortic Root Dilation

Exercise Standards for Testing and Training

Choice of prosthetic heart valve for adult patients

Bioprosthetic Valve Thrombosis

Prophylactic doses of low-molecular weight heparin as periprocedural bridging therapy in mechanical heart valve patients

Emergency Hospitalizations for Adverse Drug Events in Older Americans

ESC Working Group on Valvular Heart Disease Position Paper--heart valve clinics: organization, structure, and experiences

Aspirin plus Clopidogrel as Secondary Prevention after Stroke or Transient Ischemic Attack: A Systematic Review and Meta-Analysis

The Role of Stress Echocardiography in Valvular Heart Disease: A Current Appraisal

2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults

Aortic Valve Replacement

Reduced anticoagulation after mechanical aortic valve replacement: Interim results from the Prospective Randomized On-X Valve Anticoagulation Clinical Trial randomized Food and Drug Administration investigational device exemption trial

Longitudinal Outcome of Isolated Mitral Repair in Older Patients: Results From 14,604 Procedures Performed From 1991 to 2007

Pathophysiologic Correlates of Thromboembolism in Nonvalvular Atrial Fibrillation: II. Dense Spontaneous Echocardiographic Contrast (The Stroke Prevention in Atrial Fibrillation [SPAF-III] Study)

Reoperations on the pulmonary autograft and pulmonary homograft after the Ross procedure: An update on the German Dutch Ross Registry

Hemodynamic Deterioration of Surgically Implanted Bioprosthetic Aortic Valves

Pregnancy outcomes and cardiac complications in women with mechanical, bioprosthetic and homograft valves

Antithrombotic Therapy in Patients With Mechanical and Biological Prosthetic Heart Valves

Prospective comparison of radiologic, thoracoscopic, and pathologic staging in patients with early non-small cell lung cancer

Chemotherapy in malignant mesothelioma: a review

Modern Management of Prosthetic Valve Anticoagulation

Surgical Preparation Impairs Release of Endothelium-Derived Relaxing Factor From Human Saphenous Vein

Echocardiographic evaluation of mitral durability following valve repair in rheumatic mitral valve disease: Impact of Maze procedure

Patterns of Failure After Trimodality Therapy for Malignant Pleural Mesothelioma

Self-Management of Oral Anticoagulant Therapy: A Review

Prognostic factors of malignant mesothelioma of the pleura

Valvular Heart Disease in Pregnancy

Impact of patient-prosthesis mismatch on exercise capacity in patients after bioprosthetic aortic valve replacement

An essential role for platelet-derived growth factor in neointima formation in human saphenous vein in vitro

Pregnancy and mechanical heart valves replacement; dilemma of anticoagulation

Dabigatran versus Warfarin in the Treatment of Acute Venous Thromboembolism

Multiple and Mixed Valvular Heart Diseases

Prosthesis-patient mismatch: definition, clinical impact, and prevention

Advances in the Treatment of Malignant Pleural Mesothelioma

Is early anticoagulation with warfarin necessary after bioprosthetic aortic valve replacement?

Aortic Stenosis

The impact of prosthesis–patient mismatch on long-term survival after aortic valve replacement: a systematic review and meta-analysis of 34 observational studies comprising 27 186 patients with 133 141 patient-years

Managing Oral Anticoagulant Therapy

Long-term results after surgical treatment of paravalvular leak in the aortic and mitral position

Expression of the secreted frizzled-related protein gene family is downregulated in human mesothelioma

Cost-effectiveness of FDG-PET for staging non–small cell lung cancer: a decision analysis

Reoperation for Coronary Atherosclerosis

Trimetrexate in malignant mesothelioma: A Cancer and Leukemia Group B Phase II study.

Comparison of response to injury in organ culture of human saphenous vein and internal mammary artery

Transesophageal Echographic Determination of Aortic Invasion by Lung Cancer

Long-term follow-up of morbidity and mortality after aortic valve replacement with a mechanical valve prosthesis

Intracavitary photodynamic therapy for malignant pleural mesothelioma

Standardized endpoint definitions for transcatheter aortic valve implantation clinical trials: a consensus report from the Valve Academic Research Consortium

Very Long-Term Outcomes of the Carpentier-Edwards Perimount Aortic Valve in Patients Aged 60 or Younger

Surgical options in young adults with aortic valve disease

Oral Anticoagulants

Mitral Annular Calcification and Calcific Mitral Stenosis: Therapeutic Challenges and Considerations

Burden of valvular heart diseases: a population-based study

Malignant pleural mesothelioma

Anticoagulation During Pregnancy

Prevention, early detection, and management of complications after 328 consecutive extrapleural pneumonectomies

Factors Predictive of Survival Among 337 Patients With Mesothelioma Treated Between 1984 and 1994 by the Cancer and Leukemia Group B

Outcome of Noncardiac and Nonvascular Surgery in Patients With Mechanical Heart Valves

Long-term evaluation of biological versus mechanical prosthesis use at reoperative aortic valve replacement

Oral Anticoagulants: Mechanism of Action, Clinical Effectiveness, and Optimal Therapeutic Range

Diffuse malignant mesothelioma of the pleura in Ontario and Quebec: a retrospective study of 332 patients.

Long-term outcomes after autograft versus homograft aortic root replacement in adults with aortic valve disease: a randomised controlled trial

Rivaroxaban versus Enoxaparin for Thromboprophylaxis after Hip Arthroplasty

Ten-year comparison of pericardial tissue valves versus mechanical prostheses for aortic valve replacement in patients younger than 60 years of age

Outcomes With Transcatheter Mitral Valve Repair in the United States

Extrapleural Pneumonectomy in the Setting of a Multimodality Approach to Malignant Mesothelioma

Reinitiation of Anticoagulation After Warfarin-Associated Intracranial Hemorrhage and Mortality Risk: The Best Practice for Reinitiating Anticoagulation Therapy After Intracranial Bleeding (BRAIN) Study

Antithrombotic Therapy in Valvular Heart Disease—Native and Prosthetic

Percutaneous Mitral Valve Repair for Mitral Regurgitation in High-Risk Patients

Third Universal Definition of Myocardial Infarction

Long-term efficacy of percutaneous mitral commissurotomy for restenosis after previous mitral commissurotomy

Very late outcomes for mitral valve replacement with the Carpentier-Edwards pericardial bioprosthesis: 25-year follow-up of 450 implantations

Usefulness of Phenprocoumon for the Treatment of Obstructing Thrombus in Bioprostheses in the Aortic Valve Position

A proposed new International TNM Staging System for malignant pleural mesothelioma from the International Mesothelioma Interest Group

Clinical and Echocardiographic Impact of Functional Tricuspid Regurgitation Repair at the Time of Mitral Valve Replacement

The Pharmacology and Management of the Vitamin K Antagonists

The effect of extent of local resection on patterns of disease progression in malignant pleural mesothelioma

Survival of Transcatheter Mitral Valve Repair Compared With Surgical and Conservative Treatment in High-Surgical-Risk Patients

Comparison of Thrombolysis Versus Surgery as a First Line Therapy for Prosthetic Heart Valve Thrombosis

Recommendations for Evaluation of Prosthetic Valves With Echocardiography and Doppler Ultrasound

Metastases from Non-Small Cell Lung Cancer: Mediastinal Staging in the 1990s—Meta-analytic Comparison Of PET and CT

Dose-dependent fetal complications of warfarin in pregnant women with mechanical heart valves

Long-Term Results of Mitral Valve Repair for Regurgitation Due to Leaflet Prolapse

Chronic Mitral Regurgitation and Aortic Regurgitation

Early and long-term (one-year) effects of the association of aspirin and oral anticoagulant on thrombi and morbidity after replacement of the mitral valve with the st. jude medical prosthesis

Oral Apixaban for the Treatment of Acute Venous Thromboembolism

Extrapleural pneumonectomy in the treatment of malignant pleural mesothelioma

Node status has prognostic significance in the multimodality therapy of diffuse, malignant mesothelioma.

Thrombus Formation Following Transcatheter Aortic Valve Replacement

Sentinel Lymph Node Mapping of the Pleural Space

Advances in Malignant Mesothelioma

Mechanisms of thrombogenesis in atrial fibrillation: Virchow's triad revisited

A phase II trial of pleurectomy/decortication followed by intrapleural and systemic chemotherapy for malignant pleural mesothelioma.

Clinical Outcomes Following the Ross Procedure in Adults

Very Long-Term Outcomes of the Carpentier-Edwards Perimount Valve in Aortic Position

Impact of Prosthesis-Patient Mismatch on Long-Term Survival in Patients With Small St Jude Medical Mechanical Prostheses in the Aortic Position

INDICATIONS FOR PNEUMONECTOMY: Extrapleural Pneumonectomy

Guidelines for the Early Management of Patients With Acute Ischemic Stroke

Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomised controlled trial

Remodeling of Autologous Saphenous Vein Grafts

A Proposed New International TNM Staging System for Malignant Pleural Mesothelioma

Prosthetic Heart Valves

Improved Preservation of Saphenous Vein Grafts by the Use of Glyceryl Trinitrate–Verapamil Solution During Harvesting

High-dose methotrexate in the treatment of malignant mesothelioma of the pleura. A phase II study

Clinical presentation and natural history of benign and malignant mesothelioma.

Bioprosthetic aortic valve durability in the era of transcatheter aortic valve implantation

Lymph node staging in non-small cell lung cancer: evaluation by [18F]FDG positron emission tomography (PET)

Impact of Prosthesis-Patient Mismatch on Cardiac Events and Midterm Mortality After Aortic Valve Replacement in Patients With Pure Aortic Stenosis

Phase III Study of Pemetrexed in Combination With Cisplatin Versus Cisplatin Alone in Patients With Malignant Pleural Mesothelioma

The concept of mesothelioma in situ: implications for diagnosis and histogenesis.

Transcatheter Mitral-Valve Repair in Patients with Heart Failure

Self-Management of oral Anticoagulation in nonvalvular Atrial Fibrillation (SMAAF study)

2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy

American Heart Association/American College of Cardiology Foundation Guide to Warfarin Therapy

Diffuse Malignant Mesothelioma

Interventions for preventing post-operative atrial fibrillation in patients undergoing heart surgery

Rate, Timing, Correlates, and Outcomes of Hemodynamic Valve Deterioration After Bioprosthetic Surgical Aortic Valve Replacement

2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society in Collaboration With the Society of Thoracic Surgeons

ACC/AHA 2008 Guidelines for the Management of Adults With Congenital Heart Disease: Executive Summary

Indications for Cardiac Catheterization and Intervention in Pediatric Cardiac Disease

Comparative Effectiveness of Warfarin and New Oral Anticoagulants for the Management of Atrial Fibrillation and Venous Thromboembolism

Guidelines for Prevention of Stroke in Patients With Ischemic Stroke or Transient Ischemic Attack

Optimal Frequency of Patient Monitoring and Intensity of Oral Anticoagulation Therapy in Valvular Heart Disease

ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease

American Heart Association/American College of Cardiology Foundation guide to warfarin therapy11The American Heart Association makes every effort to avoid any actual or potential conflicts of interest that may arise as a result of an outside relationship or a personal, professional, or business interest of a member of the writing panel. Specifically, all members of the writing group are required to complete and submit a Disclosure Questionnaire showing all such relationships that might be perceived as real or potential conflicts of interest.This statement has been co-published in the April 1, 2003, issue of Circulation.This statement was approved by the American Heart Association Science Advisory and Coordinating Committee in October 2002 and by the American College of Cardiology Board of Trustees in February 2003. A single reprint is available by calling 800-242-8721 (US only) or writing the American Heart Association, Public Information, 7272 Greenville Ave, Dallas, TX 75231-4596. Ask for reprint No. 71-0254. To purchase additional reprints: up to 999 copies, call 800-611-6083 (US only) or fax 413-665-2671; 1000 or more copies, call 410-528-4426, fax 410-528-4264, or e-mail klbradle@lww.com. To make photocopies for personal or educational use, call the Copyright Clearance Center, 978-750-8400.

The value of adriamycin in the treatment of diffuse malignant pleural mesothelioma

Late Results of Percutaneous Mitral Commissurotomy up to 20 Years

Incidence and Predictors of Early and Late Mortality After Transcatheter Aortic Valve Implantation in 663 Patients With Severe Aortic Stenosis

Surgery for Infective Endocarditis

Aortocoronary Saphenous Vein Graft Disease

A Structured Teaching and Self-management Program for Patients Receiving Oral Anticoagulation<SUBTITLE>A Randomized Controlled Trial</SUBTITLE>

2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines

2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation

Evaluation of Prosthetic Heart Valves by Transesophageal Echocardiography: Problems, Pitfalls, and Timing of Echocardiography

Malignant mesothelioma of the pleura: a study of 52 treated and 64 untreated patients.

Right Ventricular Function in Cardiovascular Disease, Part I

2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation

Long-Term Survival of Patients Undergoing Mitral Valve Repair and Replacement

2015 ESC Guidelines for the management of infective endocarditis

Anticoagulation in Pregnant Women With Prosthetic Heart Valves

Intensity of oral anticoagulation after implantation of St. Jude Medical mitral or multiple valve replacement: lessons learned from GELIA (GELIA 5)

Anatomy of the Aortic Valvar Complex and Its Implications for Transcatheter Implantation of the Aortic Valve

Use of Direct Oral Anticoagulants in Patients With Atrial Fibrillation and Valvular Heart Lesions

AREVA: Multicenter Randomized Comparison of Low-Dose Versus Standard-Dose Anticoagulation in Patients With Mechanical Prosthetic Heart Valves

The impact of intraoperative transesophageal echocardiography in infective endocarditis.

The Anthracycline Antineoplastic Drugs

Impact of Prosthesis–Patient Size on Functional Recovery After Aortic Valve Replacement

Long Term Results and Predictors of Left Ventricular Function Recovery after Aortic Valve Replacement for Chronic Aortic Regurgitation

2008 Focused Update Incorporated Into the ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease

High-Dose Atorvastatin after Stroke or Transient Ischemic Attack

Late Outcomes of Mitral Valve Repair for Mitral Regurgitation Due to Degenerative Disease

The management of anticoagulation in patients with prosthetic heart valves undergoing non-cardiac operations

Guideline on antiplatelet and anticoagulation management in cardiac surgery

American Society of Clinical Oncology Treatment of Unresectable Non–Small-Cell Lung Cancer Guideline: Update 2003

Neurodevelopmental Outcomes in Children With Congenital Heart Disease: Evaluation and Management

Mechanism of Action and In Vivo Role of Platelet-Derived Growth Factor

Thrombocytosis in patients with tumors producing colony-stimulating factor

Better anticoagulation control improves survival after valve replacement

Guidelines for prevention of thromboembolic events in valvular heart disease

Guidelines for reporting mortality and morbidity after cardiac valve interventions

Pleural mesothelioma

Antithrombotic management in patients with prosthetic valves: a comparison of American and European guidelines

Morphologic Analysis of a Strand Recovered from a Prosthetic Mitral Valve: No Evidence of Fibrin

Anticoagulation variability between centres: Implications for comparative prosthetic valve assessment

Prospective study of routine perioperative transesophageal echocardiography for elective valve replacement: Clinical impact and cost-saving implications

What are the characteristics of patients with severe, symptomatic, mitral regurgitation who are denied surgery?

Recommendations for the management of patients after heart valve surgery

Prosthesis size and long-term survival after aortic valve replacement

The incidence and significance of early pericardial effusion after open heart surgery

Valvular Heart Disease in the Community: A European Experience

Therapeutic options in malignant mesothelioma

Guidelines for Reporting Mortality and Morbidity After Cardiac Valve Interventions

Twenty years' experience with the Medtronic Hall valve

Contemporary Management of Malignant Pleural Mesothelioma

Guidelines for reporting mortality and morbidity after cardiac valve interventions

Prosthetic heart valves and anticoagulant management during non-cardiac surgery

Pleuropneumonectomy in the management of diffuse malignant mesothelioma of the pleura. Experience with 29 patients.

Metabolic damage to human saphenous vein during preparation for coronary artery bypass grafting

Preoperative staging of carcinoma of the bronchus: can computed tomographic scanning reliably identify stage III tumours?

Guidelines for prevention of thromboembolic events in valvular heart disease. Ad Hoc Committee of the Working Group on Valvular Heart Disease, European Society of Cardiology.